Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

626
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

787
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
787
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

2.0K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.9K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

481
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
481

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ventricular Repolarization Abnormalities in Pediatric Athletes: A Practical Approach to Clinical Evaluation.

Journal of cardiovascular development and disease·2026
Same author

Echocardiographic Parameters and Athlete Performance: Associations and Training Profile Comparisons.

Echocardiography (Mount Kisco, N.Y.)·2026
Same author

Moderate mitral regurgitation: when to prefer clip over medical therapy.

European heart journal supplements : journal of the European Society of Cardiology·2026
Same author

High-Risk Cardiomyopathy Genotypes and Arrhythmic Risk: LMNA, FLNC, RBM20, PLN and Desmosomal Genes in the ESC 2023 Era.

Genes·2026
Same author

AI-Enabled Sensor Technologies for Remote Arrhythmic Monitoring in High-Risk Cardiomyopathy Genotypes.

Sensors (Basel, Switzerland)·2026
Same author

Diagnostic and Prognostic Value of Arterial Blood Gas and Electrolyte Analyses in Heart Failure.

Reviews in cardiovascular medicine·2026

Related Experiment Video

Updated: May 5, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

11.1K

Resting and Exercise Lactate Dynamics in Heart Failure: Guiding Therapeutic Optimization.

Aurora Ferro1,2, Andrea Segreti1,2, Nardi Tetaj1,2

  • 1Cardiology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128 Rome, Italy.

Biomedicines
|May 4, 2026
PubMed
Summary
This summary is machine-generated.

In heart failure, elevated blood lactate indicates poor tissue perfusion. Assessing lactate during exercise offers insights into disease severity and aids personalized treatment strategies.

Keywords:
anaerobic thresholdcardiopulmonary exercise testingheart failurelactatemetabolic dysfunctionpersonalized therapyrisk stratificationventilatory inefficiency

More Related Videos

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
04:20

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure

Published on: October 1, 2019

5.1K
A Rapidly Incremented Tethered-Swimming Maximal Protocol for Cardiorespiratory Assessment of Swimmers
09:24

A Rapidly Incremented Tethered-Swimming Maximal Protocol for Cardiorespiratory Assessment of Swimmers

Published on: January 28, 2020

7.8K

Related Experiment Videos

Last Updated: May 5, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

11.1K
Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
04:20

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure

Published on: October 1, 2019

5.1K
A Rapidly Incremented Tethered-Swimming Maximal Protocol for Cardiorespiratory Assessment of Swimmers
09:24

A Rapidly Incremented Tethered-Swimming Maximal Protocol for Cardiorespiratory Assessment of Swimmers

Published on: January 28, 2020

7.8K

Area of Science:

  • Cardiology
  • Exercise Physiology
  • Biochemistry

Background:

  • Elevated blood lactate in heart failure (HF) signifies impaired tissue perfusion and metabolic dysregulation.
  • Lactate is increasingly recognized as a marker of metabolic reserve and ventilatory control, beyond anaerobic metabolism.

Purpose of the Study:

  • To review current evidence on lactate dynamics in HF patients at rest and during exercise.
  • To highlight the pathophysiological and clinical significance of lactate in HF.
  • To explore lactate's role in disease severity, ventilatory control, and therapeutic monitoring.

Main Methods:

  • Narrative review of existing literature on lactate in heart failure.
  • Analysis of data from cardiopulmonary exercise testing (CPET), focusing on lactate levels and VE/VCO2 slope.
  • Examination of the impact of interventions on lactate dynamics.

Main Results:

  • HF patients exhibit earlier exercise-induced lactate accumulation, linked to impaired oxidative capacity and reduced oxygen utilization.
  • Lactate levels correlate with ventilatory inefficiency (VE/VCO2 slope) during CPET.
  • Lactate may mediate abnormal ventilatory responses and chemoreflex activation.

Conclusions:

  • Lactate assessment, especially during exercise, provides valuable insights into HF pathophysiology and disease mechanisms.
  • Lactate dynamics can improve risk stratification and guide personalized therapeutic strategies in HF.
  • Lactate monitoring may serve as a tool for evaluating treatment efficacy.